Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation
Drug Design, Development and Therapy · 2024
DOI: 10.2147/dddt.s487371 ↗Kurz gefasst
Fachartikel in der Zeitschrift Drug Design, Development and Therapy, 2024. Verfasst von Lan Liang und 7 weiteren Autor:innen. Beteiligte Einrichtung: The First Clinical Medical School, Shaanxi University of Chinese Medicine, Xianyang, People's Republic of China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Network Pharmacology, Drugs, Chinese Herbal, Molecular Dynamics Simulation. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Clinical Medical School, Shaanxi University of Chinese Medicine, Xianyang, People's Republic of China.
- College of Nursing, Shaanxi Energy Institute, Xianyang, People's Republic of China.
- LongHua Hospital, Shanghai University of Traditional Chinese Medicine, Shanghai, People's Republic of China.
- Xijing 986 Hospital Department, Air Force Medical University, Xian, People's Republic of China.
- School of Basic Medical Sciences, Shaanxi University of Chinese Medicine, Xianyang, People's Republic of China.
- School of Nursing, Shaanxi University of Chinese Medicine, Xianyang, People's Republic of China.
ORCID-Profile: Lan Liang, Chenming He
Zitieren
APA
Liang, L., He, C., Han, X., Liu, J., Yang, L., Chang, F., Zhang, Y., & Lin, J. (2024). Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation. Drug Design, Development and Therapy. https://doi.org/10.2147/dddt.s487371
Vancouver
Liang L, He C, Han X, Liu J, Yang L, Chang F, et al. Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation. Drug Design, Development and Therapy. 2024. doi:10.2147/dddt.s487371
BibTeX
@article{Liang2024,
author = {Liang, Lan and He, Chenming and Han, Xue and Liu, Jia and Yang, Liuhong and Chang, Fengjiao and Zhang, Yami and Lin, Jie},
title = {Zuojin Pill Alleviates Precancerous Lesions of Gastric Cancer by Modulating the MEK/ERK/c-Myc Pathway: An Integrated Approach of Network Pharmacology, Molecular Dynamics Simulation, and Experimental Validation},
journal = {Drug Design, Development and Therapy},
year = {2024},
doi = {10.2147/dddt.s487371}
}
EUVIMED